Amgen AMGN

NAS: AMGN | ISIN: US0311621009 8/06/2026

345,73 USD (-1,10%)

(-1,10%) 8/06/2026

Grafiek Amgen Inc

Grafiek Amgen Inc

1 dag1d -1,10%
1 week1w 5,32%
1 maand1m 4,90%
3 maanden3m -8,29%
6 maanden6m 10,16%
1 jaar1j 19,23%
5 jaar5j 44,34%

Amgen Inc in het nieuws

Toon enkel gratis nieuws

7 juni 2026 · Amgen Presents New Data Across Its Cardiometabolic Portfolio At American Diabetes Association 86Th Scientific Sessions · Persbericht

4 juni 2026 · Amgen To Present At The Goldman Sachs 47Th Annual Global Healthcare Conference · Persbericht

3 juni 2026 · La Commission Européenne Approuve Imdylltra® D'amgen Pour Le Traitement Du Cancer Du Poumon À Petites Cellules De Stade Étendu · Persbericht

3 juni 2026 · Amgen To Present New Data Across Rare Autoimmune And Inflammatory Diseases At Eular 2026 · Persbericht

29 mei 2026 · Amgen To Present At Jefferies Global Healthcare Conference · Persbericht

27 mei 2026 · Ember LifeSciences announces new strategic investments boosting Series A to $27M · Persbericht

19 mei 2026 · Amgen Announces Retirement Of Chief Financial Officer Peter Griffith · Persbericht

12 mei 2026 · Wall Street's Cardiac Bet: Where Diagnostics Meet the Money · Persbericht

7 mei 2026 · Amgen To Present At The Bank Of America Merrill Lynch Global Healthcare Conference · Persbericht

4 mei 2026 · Amgen Announces Additional $300 Million U.s. Manufacturing Investment, Totaling Nearly $2 Billion Over The Last Year · Persbericht

Profiel Amgen Inc

Gezondheidstechnologie

Productie van biologische producten

Website: www.amgen.com

Hoofdzetel: Thousand Oaks, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe